KDR and neoplasm: It can inhibit tumor angiogenesis by inhibiting vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, VEGFR-3, receptor tyrosine-protein kinase (Tie-2), and other protein kinase activity and play a role in anti-angiogenesis [22–24, 26].